anmelden
Novo Nordisk Aktie
41,18
EUR
-0,32
EUR
-0,77
%
41,27
EUR
-0,32
EUR
-0,76
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 12.12.17 | Novo Nordisk buy | UBS AG | |
| 07.12.17 | Novo Nordisk Reduce | HSBC | |
| 06.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 06.12.17 | Novo Nordisk buy | UBS AG | |
| 06.12.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 06.12.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 01.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 28.11.17 | Novo Nordisk buy | UBS AG | |
| 22.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 22.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 22.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 16.11.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 15.11.17 | Novo Nordisk Underweight | Barclays Capital | |
| 03.11.17 | Novo Nordisk Hold | S&P Capital IQ | |
| 02.11.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 02.11.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 02.11.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 02.11.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 02.11.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.11.17 | Novo Nordisk buy | UBS AG | |
| 27.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 26.10.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.10.17 | Novo Nordisk buy | UBS AG | |
| 20.10.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 19.10.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 19.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 17.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 17.10.17 | Novo Nordisk buy | UBS AG | |
| 17.10.17 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 17.10.17 | Novo Nordisk Reduce | HSBC | |
| 16.10.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 13.10.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 10.10.17 | Novo Nordisk Reduce | HSBC | |
| 09.10.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 25.09.17 | Novo Nordisk Neutral | BNP PARIBAS | |
| 18.09.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 13.09.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 07.09.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 06.09.17 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
| 24.08.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 18.08.17 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 17.08.17 | Novo Nordisk buy | UBS AG | |
| 17.08.17 | Novo Nordisk Reduce | HSBC | |
| 17.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 15.08.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 11.08.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 10.08.17 | Novo Nordisk buy | Deutsche Bank AG | |
Werbung
Werbung